• 1. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 2. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 3. Aluminium alkyl and aryloxide complexes of pyrazine and bipyridines: synthesis and structure?
  Doug Ogrin,Laura H. van Poppel,Simon G. Bott,Andrew R. Barron Dalton Trans., 2004, 3689-3694
• 4. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 5. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977

• Solvents and Organic Chemicals Organic Compounds Nucleosides, nucleotides, and analogues Purine nucleosides Purine 3'-deoxyribonucleosides
• Other Chemical Reagents

Introduction to Cordycepin (CAS No. 73-03-0) and Its Recent Research Findings

Cordycepin, chemically known as 3′-hydroxyadenine, is a naturally occurring nucleoside derivative found primarily in certain species of the Cordyceps fungus. With a CAS number of 73-03-0, this compound has garnered significant attention in the field of pharmaceutical research due to its unique biological properties and potential therapeutic applications. This article provides an in-depth exploration of Cordycepin, highlighting its chemical structure, pharmacological effects, and the latest research findings that underscore its significance in modern medicine.

The chemical structure of Cordycepin closely resembles that of adenosine, a naturally occurring nucleoside essential for cellular metabolism. However, Cordycepin features a hydroxyl group at the 3′ position of the ribose sugar, which distinguishes it from adenosine. This structural modification imparts distinct pharmacological activities, making Cordycepin a subject of extensive scientific investigation. The compound is known for its potent biological effects, including anti-inflammatory, antioxidant, and anticancer properties, which have been the focus of numerous preclinical and clinical studies.

One of the most compelling aspects of Cordycepin is its ability to modulate various cellular pathways involved in cancer progression. Recent studies have demonstrated that Cordycepin can induce apoptosis (programmed cell death) in cancer cells while sparing healthy cells. This selective toxicity is attributed to its ability to inhibit enzymes such as adenosine deaminase (ADA) and deoxyhypusine synthase (DHS), which are crucial for cancer cell survival. Additionally, Cordycepin has been shown to disrupt tumor blood vessel formation (angiogenesis), further inhibiting cancer growth and metastasis.

In the realm of immunomodulation, Cordycepin has emerged as a promising immunostimulant. Research indicates that it can enhance the activity of natural killer (NK) cells and T-lymphocytes, key components of the immune system responsible for identifying and destroying pathogens. These findings suggest that Cordycepin may be beneficial in treating immunodeficient conditions and enhancing vaccine efficacy. Furthermore, studies have explored its potential role in managing chronic inflammatory diseases by suppressing pro-inflammatory cytokines such as TNF-α and IL-6.

The antioxidant properties of Cordycepin have also been extensively studied. Oxidative stress, resulting from an imbalance between free radicals and antioxidants, is implicated in various chronic diseases, including neurodegenerative disorders like Alzheimer's disease and Parkinson's disease. Preclinical research has shown that Cordycepin can scavenge reactive oxygen species (ROS) and protect against oxidative damage in neuronal cells. These findings have opened new avenues for investigating Cordycepin as a potential therapeutic agent for neuroprotection.

Recent advances in clinical trials have provided further evidence of Cordycepin's therapeutic potential. A notable study published in a peer-reviewed journal demonstrated that Cordycepin, when combined with conventional chemotherapy, significantly improved outcomes in patients with certain types of cancer. The study reported reduced tumor burden and prolonged survival rates among participants receiving the combination therapy. While more research is needed to confirm these findings and establish optimal dosing regimens, these results are highly encouraging for future clinical applications.

The pharmacokinetics of Cordycepin have also been a focus of research efforts. Studies have shown that the compound exhibits moderate bioavailability upon oral administration but undergoes rapid metabolism in vivo. To enhance its therapeutic efficacy, researchers are exploring novel delivery systems such as nanoparticles and liposomes, which could improve drug delivery and target specificity. Additionally, investigations into the compound's mechanism of action at the molecular level are providing valuable insights into its interactions with cellular targets.

The natural sources of Cordycepin have also been a subject of interest. While traditionally sourced from fungal species like *Cordyceps militaris*, advancements in biotechnology have enabled synthetic production methods that are more sustainable and scalable. These developments not only ensure a consistent supply of high-quality Cordycepin but also reduce dependency on wild-cultivated sources, which may be subject to environmental variability and contamination risks.

In conclusion, Cordycepin (CAS No. 73-03-0) is a multifaceted compound with significant therapeutic potential across various medical conditions. Its unique chemical structure and biological activities make it a valuable candidate for further research and development. The latest findings from preclinical and clinical studies highlight its promise as an anticancer agent, immunomodulator, antioxidant, and neuroprotective compound. As research continues to uncover new applications for this remarkable natural product, it is poised to play an increasingly important role in modern medicine.

• 46946-45-6((2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol)
• 6998-75-0(9H-Purin-6-amine, 9-(3-deoxy-beta-D-threo-pentofuranosyl)-)
• 303197-30-0(3'-O-(2-Methoxyethyl)adenosine)
• 13116-38-6(2-(6-aminopurin-9-yl)-5-methyloxolan-3-ol)
• 20649-45-0(5'-O-Methyl-adenosin)
• 82741-17-1(Adenosine-d)
• 13137-27-4
• 46969-16-8((2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol)
• 123179-97-5(2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol)
• 202406-75-5(Adenosine-\u200b13C10-\u200b15N5)